18546628

Source:http://linkedlifedata.com/resource/pubmed/id/18546628

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0039796, umls-concept:C0044602, umls-concept:C0205245, umls-concept:C0205369, umls-concept:C0285761, umls-concept:C0599894, umls-concept:C0872252, umls-concept:C1150481, umls-concept:C1368105, umls-concept:C1451005, umls-concept:C1513397, umls-concept:C1704259, umls-concept:C1705325, umls-concept:C1705987, umls-concept:C1707391, umls-concept:C1881197
pubmed:dateCreated	2008-6-12
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/1 T90 070109-01
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0121103
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylinositol 3-Kinases, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
pubmed:status	MEDLINE
pubmed:issn	0065-2598
pubmed:author	pubmed-author:CoombesKevin RKR, pubmed-author:HennessyBryanB, pubmed-author:JoyCorwinC, pubmed-author:LuYilingY, pubmed-author:MillsGordon BGB, pubmed-author:MurphMandi MMM, pubmed-author:SmithDebra LDL
pubmed:issnType	Print
pubmed:volume	622
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	183-95
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:18546628-Antineoplastic Agents, pubmed-meshheading:18546628-Clinical Trials as Topic, pubmed-meshheading:18546628-Enzyme-Linked Immunosorbent Assay, pubmed-meshheading:18546628-Humans, pubmed-meshheading:18546628-Neoplasms, pubmed-meshheading:18546628-Phosphatidylinositol 3-Kinases, pubmed-meshheading:18546628-Proteomics, pubmed-meshheading:18546628-Tumor Markers, Biological
pubmed:year	2008
pubmed:articleTitle	Individualized molecular medicine: linking functional proteomics to select therapeutics targeting the PI3K pathway for specific patients.
pubmed:publicationType	Journal Article, Review, Research Support, N.I.H., Extramural